KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Capital Leases (2016 - 2018)

Historic Capital Leases for Exact Sciences (EXAS) over the last 7 years, with Q4 2018 value amounting to $8.2 million.

  • Exact Sciences' Capital Leases rose 696379.31% to $8.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $8.2 million, marking a year-over-year increase of 696379.31%. This contributed to the annual value of $8.2 million for FY2018, which is 696379.31% up from last year.
  • As of Q4 2018, Exact Sciences' Capital Leases stood at $8.2 million, which was up 696379.31% from $116000.0 recorded in Q4 2017.
  • In the past 5 years, Exact Sciences' Capital Leases registered a high of $8.2 million during Q4 2018, and its lowest value of $116000.0 during Q4 2017.
  • Its 5-year average for Capital Leases is $1.5 million, with a median of $1.1 million in 2016.
  • Per our database at Business Quant, Exact Sciences' Capital Leases plummeted by 8309.04% in 2017 and then skyrocketed by 696379.31% in 2018.
  • Exact Sciences' Capital Leases (Quarter) stood at $1.6 million in 2014, then crashed by 34.26% to $1.1 million in 2015, then tumbled by 35.34% to $686000.0 in 2016, then plummeted by 83.09% to $116000.0 in 2017, then surged by 6963.79% to $8.2 million in 2018.
  • Its Capital Leases was $8.2 million in Q4 2018, compared to $116000.0 in Q4 2017 and $224000.0 in Q3 2017.